From oil giants to banks - these companies are making billions from Iran war

The Iran war is driving a broad market repricing, with higher energy volatility boosting profits across oil majors, banks, defense contractors, and renewable-energy firms. BP more than doubled first-quarter profit to $3.2bn, Shell rose to $6.92bn, TotalEnergies jumped to $5.4bn, and the Big Six U.S. banks reported $47.7bn in first-quarter profits, led by JPMorgan trading revenue of $11.6bn. Defense names cite stronger spending and record backlogs, while renewables and EVs are benefiting from the push to diversify away from fossil fuels.

Analysis

The market is rewarding three distinct “geopolitical convexity” trades: balance-sheet-heavy oil majors with trading arms, bank market-makers, and defense primes with backlog visibility. The first-order move is obvious, but the second-order effect is that volatility itself is now the product, which tends to shift earnings quality upward for firms with inventory, trading, or order-book optionality and downward for firms exposed to fixed-price procurement or end-demand elasticity.

Within energy, the dispersion matters more than the headline. The European integrated names with stronger commodity trading franchises have a cleaner earnings lever than US peers, whose benefit is partly offset by domestic production disruption and weaker realization stability; that suggests the current rally can keep rewarding SHEL/TTE over CVX if volatility persists another 1-2 quarters. The real risk is that once tanker routes normalize or policymakers create a credible corridor, trading profits mean-revert faster than upstream cash flows, making these names vulnerable to a sharp multiple compression even if oil stays elevated.

Banks are likely seeing a transient but powerful boost from cross-asset turnover rather than a durable improvement in fundamentals. That favors the diversified flow franchises most over lenders with more rate-sensitive or credit-sensitive earnings; Morgan Stanley and JPM should keep taking share if volatility remains elevated, but the set-up is weaker for the more cyclical consumer-bank complex once risk appetite stabilizes. Defense is more structurally constructive: the key shift is not one-quarter demand, but a multi-year re-acceleration in European air defense and munitions replenishment, which supports backlog conversion more than headline order growth.

The contrarian read is that the “war winners” basket may be getting too crowded too quickly, especially defense and utilities/renewables. If investors are already paying for a prolonged conflict, the better trade may be to own the names with near-term cash flow inflection and short the beneficiaries whose valuation already discounts several years of sustained tension. Renewables are the cleanest under-owned second-order winner because energy insecurity can improve policy support and retail adoption faster than institutional capital allocation, but the move is likely more gradual than the market is pricing.

Key Decisions for Investors

• Long SHEL vs short CVX for the next 1-2 quarters: favor the name with stronger trading optionality and higher sensitivity to sustained volatility; cover if crude normalizes or if Strait-risk headlines fade.
• Buy JPM or MS on pullbacks, but express it with call spreads 3-6 months out: thesis is elevated trading revenues and market share gains, with the risk that volumes revert once volatility compresses.
• Long LMT/NOC on any post-rally consolidation as a 6-12 month thematic hold: backlog and replenishment cycles should outlast the headline conflict, with better risk/reward than chasing already-extended shares.
• Pair long NEE vs short a high-beta defense/energy basket for a 6-12 month horizon: the market is underappreciating the policy and demand pull-through from energy-security capex; use as a lower-volatility way to own the second-order winner.
• Avoid chasing additional upside in BA and broad defense after recent strength; if positioning remains crowded, use put spreads as a hedge against a ceasefire-driven de-risking in the next 1-3 months.